These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

247 related items for PubMed ID: 26167079

  • 1. Clinical predictors of thiopurine-related adverse events in Crohn's disease.
    Moran GW, Dubeau MF, Kaplan GG, Yang H, Eksteen B, Ghosh S, Panaccione R.
    World J Gastroenterol; 2015 Jul 07; 21(25):7795-804. PubMed ID: 26167079
    [Abstract] [Full Text] [Related]

  • 2. Phenotypic features of Crohn's disease associated with failure of medical treatment.
    Moran GW, Dubeau MF, Kaplan GG, Yang H, Seow CH, Fedorak RN, Dieleman LA, Barkema HW, Ghosh S, Panaccione R, Alberta Inflammatory Bowel Disease Consortium.
    Clin Gastroenterol Hepatol; 2014 Mar 07; 12(3):434-42.e1. PubMed ID: 23978351
    [Abstract] [Full Text] [Related]

  • 3. Birth outcome in women with ulcerative colitis and Crohn's disease, and pharmacoepidemiological aspects of anti-inflammatory drug therapy.
    Nørgård BM.
    Dan Med Bull; 2011 Dec 07; 58(12):B4360. PubMed ID: 22142578
    [Abstract] [Full Text] [Related]

  • 4. Identification of Patients With Variants in TPMT and Dose Reduction Reduces Hematologic Events During Thiopurine Treatment of Inflammatory Bowel Disease.
    Coenen MJ, de Jong DJ, van Marrewijk CJ, Derijks LJ, Vermeulen SH, Wong DR, Klungel OH, Verbeek AL, Hooymans PM, Peters WH, te Morsche RH, Newman WG, Scheffer H, Guchelaar HJ, Franke B, TOPIC Recruitment Team.
    Gastroenterology; 2015 Oct 07; 149(4):907-17.e7. PubMed ID: 26072396
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The impact of thiopurines on the risk of surgical recurrence in patients with Crohn's disease after first intestinal surgery.
    Papay P, Reinisch W, Ho E, Gratzer C, Lissner D, Herkner H, Riss S, Dejaco C, Miehsler W, Vogelsang H, Novacek G.
    Am J Gastroenterol; 2010 May 07; 105(5):1158-64. PubMed ID: 20010925
    [Abstract] [Full Text] [Related]

  • 7. Routinely Established Skewed Thiopurine Metabolism Leads to a Strikingly High Rate of Early Therapeutic Failure in Patients With Inflammatory Bowel Disease.
    Kreijne JE, Seinen ML, Wilhelm AJ, Bouma G, Mulder CJ, van Bodegraven AA, de Boer NK.
    Ther Drug Monit; 2015 Dec 07; 37(6):797-804. PubMed ID: 25853923
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Thiopurines related malignancies in inflammatory bowel disease: local experience in Granada, Spain.
    Gómez-García M, Cabello-Tapia MJ, Sánchez-Capilla AD, De Teresa-Galván J, Redondo-Cerezo E.
    World J Gastroenterol; 2013 Aug 14; 19(30):4877-86. PubMed ID: 23946592
    [Abstract] [Full Text] [Related]

  • 10. Risk of lymphoma in patients with ulcerative colitis treated with thiopurines: a nationwide retrospective cohort study.
    Khan N, Abbas AM, Lichtenstein GR, Loftus EV, Bazzano LA.
    Gastroenterology; 2013 Nov 14; 145(5):1007-1015.e3. PubMed ID: 23891975
    [Abstract] [Full Text] [Related]

  • 11. Timing of Thiopurine or Anti-TNF Initiation Is Associated with the Risk of Major Abdominal Surgery in Crohn's Disease: A Retrospective Cohort Study.
    González-Lama Y, Suárez C, González-Partida I, Calvo M, Matallana V, de la Revilla J, Magaz M, Bernardo C, Agudo B, Ibarrola P, Relea L, Arévalo J, Vera MI, Abreu L.
    J Crohns Colitis; 2016 Jan 14; 10(1):55-60. PubMed ID: 26520164
    [Abstract] [Full Text] [Related]

  • 12. Thiopurine metabolites variations during co-treatment with aminosalicylates for inflammatory bowel disease: effect of N-acetyl transferase polymorphisms.
    Stocco G, Cuzzoni E, De Iudicibus S, Favretto D, Malusà N, Martelossi S, Pozzi E, Lionetti P, Ventura A, Decorti G.
    World J Gastroenterol; 2015 Mar 28; 21(12):3571-8. PubMed ID: 25834322
    [Abstract] [Full Text] [Related]

  • 13. Risk Factors for Rescue Therapy in Crohn's Patients Maintained on Infliximab After Withdrawal of the Immunomodulator: A Long-Term Follow-Up.
    Fischer M, Campbell SC, Calley CSJ, Helper DJ, Chiorean MV, Fadda HM.
    Dig Dis Sci; 2017 Nov 28; 62(11):3131-3137. PubMed ID: 28986660
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Thiopurine therapy in inflammatory bowel disease.
    Ha C, Dassopoulos T.
    Expert Rev Gastroenterol Hepatol; 2010 Oct 28; 4(5):575-88. PubMed ID: 20932143
    [Abstract] [Full Text] [Related]

  • 16. Addition of thiopurines can recapture response in patients with Crohn's disease who have lost response to anti-tumor necrosis factor monotherapy.
    Ong DE, Kamm MA, Hartono JL, Lust M.
    J Gastroenterol Hepatol; 2013 Oct 28; 28(10):1595-9. PubMed ID: 23662928
    [Abstract] [Full Text] [Related]

  • 17. Infliximab Is Not Associated With Increased Risk of Malignancy or Hemophagocytic Lymphohistiocytosis in Pediatric Patients With Inflammatory Bowel Disease.
    Hyams JS, Dubinsky MC, Baldassano RN, Colletti RB, Cucchiara S, Escher J, Faubion W, Fell J, Gold BD, Griffiths A, Koletzko S, Kugathasan S, Markowitz J, Ruemmele FM, Veereman G, Winter H, Masel N, Shin CR, Tang KL, Thayu M.
    Gastroenterology; 2017 Jun 28; 152(8):1901-1914.e3. PubMed ID: 28193515
    [Abstract] [Full Text] [Related]

  • 18. Adverse events of thiopurine immunomodulators in patients with inflammatory bowel disease.
    López-Martín C, Chaparro M, Espinosa L, Bejerano A, Maté J, Gisbert JP.
    Gastroenterol Hepatol; 2011 Jun 28; 34(6):385-92. PubMed ID: 21616565
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Long-term effect of NUDT15 R139C on hematologic indices in inflammatory bowel disease patients treated with thiopurine.
    Akiyama S, Matsuoka K, Fukuda K, Hamada S, Shimizu M, Nanki K, Mizuno S, Kiyohara H, Arai M, Sugimoto S, Iwao Y, Ogata H, Hisamatsu T, Naganuma M, Motobayashi M, Suzuki K, Takenaka K, Fujii T, Saito E, Nagahori M, Ohtsuka K, Mochizuki M, Watanabe M, Hashiguchi M, Kanai T.
    J Gastroenterol Hepatol; 2019 Oct 28; 34(10):1751-1757. PubMed ID: 31045285
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.